Valeant on Wednesday offered to pay $58.30 per Allergan share in cash, about $10 higher than its previous offer of $48.30. The stock component of the offer remains the same at 0.83 of a Valeant share for each Allergan share The new offer values Allergan at $166.16 per share as of Tuesday's closing price, and is about 8.6 percent higher than the previous bid of $153 as on April 22 when Valeant first made its offer. That offer, by Valeant and activist investor Bill Ackman, was worth $47 billion and was spurned by Allergan, which said the Canadian company had overstated the possible savings from the deal.
via Business News - Yahoo Finance http://ift.tt/SPgPhL
0 commentaires:
Enregistrer un commentaire